PUT - SPRINTER OPEN END - BIOGEN IDEC | Delayed Deutsche Boerse AG 04:21:09 2024-06-03 am EDT | ||
| 10.55 EUR | -1.03% |
|
| 1 month | -7.55% | ||
| 3 months | -3.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 10.55 | -1.03% |
| 24-05-31 | 10.66 | -4.99% |
| 24-05-30 | 11.22 | -2.94% |
| 24-05-29 | 11.56 | +2.12% |
| 24-05-28 | 11.32 | +1.07% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 04:21 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VX03JC |
| ISIN | DE000VX03JC4 |
| Date issued | 2021-09-02 |
| Strike | 337.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.27 € |
|---|---|
| Lowest since issue | 0.6 € |
| Spread | 0.16 € |
| Spread % | 1.50% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
